Abstract
Human telomeres are essential for genome stability and are composed of long simple tandem repeat arrays (STRs), comprising the consensus TTAGGG repeat interspersed, at the proximal end, with sequence–variant repeats. While the dynamics of telomere attrition through incomplete replication has been studied extensively, the effects on telomeres of error-prone DNA repair processes, known to affect other STRs, are poorly understood. We have compared the TTAGGG and sequence–variant interspersion patterns in the proximal 720 bp of telomeres in colon cancer and normal DNA samples. The frequency of telomere mutations was 5.8% per allele in a randomly collected panel of sporadic colon cancers, showing that telomere mutations occur in vivo. The mutation frequency rose to 18.6% per allele in sporadic tumours that exhibit instability at the polyA tract in the TGFβRII gene and to 35% per allele in tumours with somatic mutations in the hMSH2 gene. The majority of the characterized mutations resulted in the loss of one or a few repeats. If the mutation spectrum and frequency described here is reiterated in the rest of the array, there is the potential for extensive telomere destabilization especially in mismatch repair-defective cells. This may in turn lead to a greater requirement for telomere length maintenance earlier in tumourigenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, Hamilton SR, Petersen GM, Kinzler KW, Vogelstein B and Delachapelle A . (1993). Science, 260, 812–816.
Aaltonen LA, Peltomaki P, Mecklin JP, Jarvinen H, Jass JR, Green JS, Lynch HT, Watson P, Tallqvist G and Juhola M . (1994). Cancer Res., 54, 1645–1648.
Allshire RC, Dempster M and Hastie ND . (1989). Nucleic Acids Res., 17, 4611–4627.
Baird DM, Coleman J, Rosser ZH and Royle NJ . (2000). Am. J. Hum. Genet., 66, 235–250.
Baird DM, Jeffreys AJ and Royle NJ . (1995). EMBO J., 14, 5433–5443.
Baird DM and Royle NJ . (1997). Hum. Mol. Genet., 6, 2291–2299.
Borresen AL, Lothe RA, Meling GI, Lystad S, Morrison P, Lipford J, Kane MF, Rognum TO and Kolodner RD . (1995). Hum. Mol. Genet., 4, 2065–2072.
Bryan TM, Englezou A, Gupta J, Bacchetti S and Reddel RR . (1995). EMBO J., 14, 4240–4248.
Cheng AJ, Tang RP, Wang JY, See LC and Wang TCV . (1998). J. Natl. Cancer Inst., 90, 316–321.
Coleman J, Baird DM and Royle NJ . (1999). Hum. Mol. Genet., 8, 1637–1646.
Coleman MG, Gough AC, Bunyan DJ, Braham D, Eccles DM and Primrose JN . (2001). Br. J. Cancer, 85, 1486–1491.
Crawford DC, Wilson B and Sherman SL . (2000). Hum. Mol. Genet., 9, 2909–2918.
Dunham MA, Neumann AA, Fasching CL and Reddel RR . (2000). Nat. Genet., 26, 447–450.
Ellegren H . (2000). Nat. Genet., 24, 400–402.
Eshleman JR, Casey G, Kochera ME, Sedwick WD, Swinler SE, Veigl ML, Willson JKV, Schwartz S and Markowitz SD . (1998). Oncogene, 17, 719–725.
Fortune MT, Vassilopoulos C, Coolbaugh MI, Siciliano MJ and Monckton DG . (2000). Hum. Mol. Genet., 9, 439–445.
Harfe BD and Jinks-Robertson S . (2000). Annu. Rev. Genet., 34, 359–399.
Harley CB, Futcher AB and Greider CW . (1990). Nature (London), 345, 458–460.
Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK and Allshire RC . (1990). Nature, 346, 866–868.
Hoff-Olsen P, Meling GI and Olaisen B . (1995). Hum. Mutat., 5, 329–332.
Jeffreys AJ, MacLeod A, Tamaki K, Neil DL and Monckton DG . (1991). Nature, 354, 204–209.
Jiricny J and Marra G . (2003). Curr. Opin. Genet. Dev., 13, 61–69.
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho P, coviello GM, Wright WE, Weinrich SL and Shay JW . (1994). Science, 266, 2011–2015.
Kolodner RD and Marsischky GT . (1999). Curr. Opin. Genet. Dev., 9, 89–96.
Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, Jass JR, Dunlop M, Wyllie A, Peltomaki P, de la Chapelle A, Hamilton SR, Vogelstein B and Kinzler KW . (1996). Nat. Med., 2, 169–174.
Lothe RA, Peltomaki P, Meling GI, Aaltonen LA, Nystrom-Lahti M, Pylkkanen L, Heimdal K, Andersen TI, Moller P and Rognum TO . (1993). Cancer Res., 53, 5849–5852.
Lundblad V . (2002). Oncogene, 21, 522–531.
Lundblad V and Blackburn EH . (1993). Cell, 73, 347–360.
Martorell L, Monckton DG, Gamez J, Johnson KJ, Gich I, de Munain AL and Baiget M . (1998). Hum. Mol. Genet., 7, 307–312.
Monckton DG, Wong LJ, Ashizawa T and Caskey CT . (1995). Hum. Mol. Genet., 4, 1–8.
Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW and Vogelstein B . (1995). Cancer Res., 55, 5548–5550.
Rizki A and Lundblad V . (2001). Nature, 411, 713–716.
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB and Erlich HA . (1988). Science, 239, 487–491.
Savouret C, Brisson E, Essers J, Kanaar R, Pastink A, te Riele H, Junien C and Gourdon G . (2003). EMBO J., 22, 2264–2273.
Sharma R, Bhatti S, Gomez M, Clark RM, Murray C, Ashizawa T and Bidichandani SI . (2002). Hum. Mol. Genet., 11, 2175–2187.
Sinden RR . (2001). Nature, 411, 757–758.
Takagi S, Kinouchi Y, Hiwatashi N, Nagashima F, Chida M, Takahashi S, Negoro K, Shimosegawa T and Toyota T . (2000). Dis. Colon Rectum, 43, S12–S17.
Thibodeau SN, Bren G and Schaid D . (1993). Science, 260, 816–819.
van den Broek WJ, Nelen MR, Wansink DG, Coerwinkel MM, te Riele H, Groenen PJ and Wieringa B . (2002). Hum. Mol. Genet., 11, 191–198.
Varley H, Pickett HA, Foxon JL, Reddel RR and Royle NJ . (2002). Nat. Genet., 30, 301–305.
Xu X, Peng M and Fang Z . (2000). Nat. Genet., 24, 396–399.
Yamamoto H, Perez-Piteira J, Yoshida T, Terada M, Itoh F, Imai K and Perucho M . (1999). Gastroenterology, 116, 1348–1357.
Acknowledgements
We thank Jenny Foxon for technical support, and Celia May, Jenny Jeypalan and Mark Hills for helpful discussion. We gratefully acknowledge the support of the MRC (UK) that funded the work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pickett, H., Baird, D., Hoff-Olsen, P. et al. Telomere instability detected in sporadic colon cancers, some showing mutations in a mismatch repair gene. Oncogene 23, 3434–3443 (2004). https://doi.org/10.1038/sj.onc.1207477
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207477
Keywords
This article is cited by
-
Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome
European Journal of Human Genetics (2013)
-
Msh2 deficiency leads to chromosomal abnormalities, centrosome amplification, and telomere capping defect
Oncogene (2006)